LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.
about
Lymphocyte-activation gene-3, an important immune checkpoint in cancerGARP: a surface molecule of regulatory T cells that is involved in the regulatory function and TGF-β releasingImmune Checkpoint Modulation in Colorectal Cancer: What's New and What to ExpectThe Regulation of CD4(+) T Cell Responses during Protozoan InfectionsThe role of regulatory T cells in cancer immunologyTargeting Immune Regulatory Networks to Counteract Immune Suppression in CancerIn situ prior proliferation of CD4+ CCR6+ regulatory T cells facilitated by TGF-β secreting DCs is crucial for their enrichment and suppression in tumor immunity.Antibody-mediated depletion of lymphocyte-activation gene-3 (LAG-3(+) )-activated T lymphocytes prevents delayed-type hypersensitivity in non-human primates.Expression of CD39 on FoxP3+ T regulatory cells correlates with progression of HBV infection.Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment.Resolving the identity myth: key markers of functional CD4+FoxP3+ regulatory T cells.Fat-1 transgenic cattle as a model to study the function of ω-3 fatty acidsAdoptive cell therapy for lymphoma with CD4 T cells depleted of CD137-expressing regulatory T cells.Challenges and future perspectives of T cell immunotherapy in cancerImmune Checkpoint Blockade to Improve Tumor Infiltrating Lymphocytes for Adoptive Cell Therapy.Broad induction of immunoregulatory mechanisms after a short course of anti-IL-7Rα antibodies in NOD mice.Myeloid-derived suppressor cells from tumor-bearing mice impair TGF-β-induced differentiation of CD4+CD25+FoxP3+ Tregs from CD4+CD25-FoxP3- T cellsLAG-3 in Cancer Immunotherapy.Antisense oligonucleotide treatment enhances the recovery of acute lung injury through IL-10-secreting M2-like macrophage-induced expansion of CD4+ regulatory T cells.Effects of cyclophosphamide and IL-2 on regulatory CD4+ T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response.Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients.Type I Interferons Regulate Immune Responses in Humans with Blood-Stage Plasmodium falciparum Infection.Expression of GARP Is Increased in Tumor-Infiltrating Regulatory T Cells and Is Correlated to Clinicopathology of Lung Cancer PatientsT regulatory cells in cancer: recent advances and therapeutic potential.The CD4-like molecule LAG-3, biology and therapeutic applications.Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance.T regulatory cells in B-cell malignancy - tumour support or kiss of death?Targeting regulatory T cells.The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells.Natural and induced T regulatory cells in cancer.Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer.Induced regulatory T cells in inhibitory microenvironments created by cancer.Emerging roles of regulatory T cells in tumour progression and metastasis.microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response.Regulatory T cells and potential inmmunotherapeutic targets in lung cancer.The functional and prognostic implications of regulatory T cells in colorectal carcinoma.Emerging immune checkpoints for cancer therapy.Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors.Treg subsets in inflammatory bowel disease and colorectal carcinoma: Characteristics, role, and therapeutic targets.Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.
P2860
Q26746209-108C69FC-A195-4CE6-9AC3-BFD63E417FACQ26752197-7089D848-8265-4691-81A8-AED702F46701Q26775578-EC2C3AE6-39E7-4AFC-B0E8-19608D097607Q26865518-AD32A184-0E9F-4824-9F9A-2D491AB0F7E2Q27006663-E18524F6-B2DD-48F6-B45B-FB7114CE1BD0Q28066486-8240BEF2-B96D-455D-A111-DD805A3A934FQ33927127-83124BED-4412-45AD-B27F-145A0149CF24Q34166913-5D39D424-177F-45AF-AC63-72D537962100Q34226860-0E426BDD-43A2-4739-A00A-62175D408F3BQ35096435-0C22E86F-3D96-47C7-8F3A-E785FCF16059Q35242154-EC6A5253-A6EC-43F4-9775-7EFCE7611DCBQ35704335-424FFF91-473F-4109-AF7E-504124C64197Q35803631-A12184D9-634D-4177-ADE3-90078016D735Q35843507-E3D19DE3-F2F4-429E-9C42-68F4AEF9EBC2Q35981245-2F4B4FF3-4B55-49B3-85F2-529424663F57Q36327212-808D8CEF-C6CB-4083-81BA-38D0A5066F84Q36332711-B2F6569F-20B6-4DFB-B644-EC44445DB7B8Q36416383-B7BAFA18-39AE-4A42-A46F-B8AE755F18C2Q36748254-73F621B8-1689-4B49-9687-03CD47DB867CQ36791766-B6CBE9E7-CE82-428D-A037-96486A7AC16DQ37323082-9B4DB737-F664-40EB-9455-705BEBB86E1AQ37371463-12800C15-5AFE-4584-9055-02682CB9FBF0Q37639474-08ADDA40-5EC6-4453-B840-67B080041AFBQ37800935-06EF89AF-9D17-46DC-9295-EEB7B62AE1C5Q37818246-B9430269-7F00-4DDB-9A83-496E4A8BB0FEQ37945304-ABC3FAB6-0325-4140-95F8-522570A4703FQ37960166-2758ECAA-A6DA-439A-BA68-556753EE0A2EQ37983467-22F92A0E-8D35-47F8-8353-CB7BC5EC1597Q38008355-FEE27F52-BA84-4777-9E76-68D1B0BC58FDQ38123165-49F95B8A-04D9-43E5-B1BC-0255A7E17960Q38198735-279BF0FE-4266-4270-A2EE-0931808EAF4FQ38220701-1D0337A1-2952-47C6-A3CA-95811A344B4AQ38264092-DE852DFC-4310-4936-A709-D7384201B6A4Q38376771-64A8D3DA-7D3D-498B-8F9A-4597146BFD57Q38473314-E6239E5F-0485-4D1C-9E19-220A48FF8EB8Q38510263-87D36466-74D6-4C20-BF0A-280D470A5391Q38584979-BCB9D87C-B304-4CA6-97BD-9DA836024514Q38730989-3223D442-2004-45B1-95A1-7B85B58A1395Q38779612-7542BFDD-F80F-40BD-8606-345BD1703D6AQ38823649-0A121EA1-E8FB-4570-B16C-2769AB01B0F8
P2860
LAG-3 expression defines a subset of CD4(+)CD25(high)Foxp3(+) regulatory T cells that are expanded at tumor sites.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
LAG-3 expression defines a subset of CD4
@nl
LAG-3 expression defines a sub ...... t are expanded at tumor sites.
@ast
LAG-3 expression defines a sub ...... t are expanded at tumor sites.
@en
type
label
LAG-3 expression defines a subset of CD4
@nl
LAG-3 expression defines a sub ...... t are expanded at tumor sites.
@ast
LAG-3 expression defines a sub ...... t are expanded at tumor sites.
@en
prefLabel
LAG-3 expression defines a subset of CD4
@nl
LAG-3 expression defines a sub ...... t are expanded at tumor sites.
@ast
LAG-3 expression defines a sub ...... t are expanded at tumor sites.
@en
P2093
P50
P356
P1476
LAG-3 expression defines a sub ...... t are expanded at tumor sites.
@en
P2093
Annamaria De Filippo
Chiara Casati
Filiberto Belli
Francesca Rini
Frédéric Triebel
Giorgio Parmiani
P304
P356
10.4049/JIMMUNOL.0903879
P407
P577
2010-04-26T00:00:00Z